Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Cancer Discov. 2020 Dec 4;11(3):626–637. doi: 10.1158/2159-8290.CD-20-1579

Figure 2.

Figure 2.

Mutational landscape and clinical outcome of Black and White patients with AML aged <60 years who were treated on the CALGB/Alliance study protocols. A, oncoprint of gene mutations detected in Black patients. B, disease-free and C overall survival of younger Black and White patients. D, forest plot illustrating multivariable analyses of overall survival of patients aged <60 years.